Nour Tashtish
Cardiovascular Disease · Cambridge, OHNPI 1477935989
Payments from drug & device makers
What this record shows
This record is dominated by grants: $72,500 of the $82,596 with a category attached, or 87.8%. Boston Scientific accounts for 62.3% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2023 at $65,990 and has fallen 96.8% since, to $2,100 in 2025. Among cardiovascular disease clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $363.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$51K
- Abbott$24K
- Medtronic$2K
- Penumbra, Inc.$945
- Pfizer$415
- Stryker$404
- plus $3K from 28 others
What the payments were for
- Grants$72,50088%
- Travel & lodging$1,3252%
- Food & beverage$8,21610%
- Education$5551%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 9 | $51,464 |
| Abbott | 25 | $23,913 |
| Medtronic | 46 | $2,276 |
| Penumbra, Inc. | 8 | $945 |
| Pfizer | 22 | $415 |
| Stryker | 4 | $404 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $308 |
| Johnson & Johnson | 15 | $306 |
| Atricure, Inc. | 14 | $241 |
| Surmodics, Inc. | 1 | $187 |
| E.r. Squibb & Sons, L.L.C. | 11 | $170 |
| Amgen | 5 | $166 |
| Cardiva Medical, Inc. | 2 | $160 |
| Shockwave Medical, Inc | 1 | $156 |
| Bard Peripheral Vascular, Inc. | 1 | $126 |
| Bayer | 2 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $111 |
| Rigel Pharmaceuticals, Inc. | 1 | $110 |
| AstraZeneca(2 entities) | 6 | $103 |
| Inquis Medical, Inc. | 3 | $97 |
| Angiodynamics, Inc. | 2 | $96 |
| Chiesi USA, Inc. | 2 | $95 |
| Novartis | 4 | $94 |
| Lantheus Medical Imaging, Inc. | 4 | $92 |
| Boehringer Ingelheim | 4 | $84 |
| Abiomed | 3 | $74 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $59 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Merck | 2 | $40 |
| Gilead | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Sanofi | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$714
- HawkOne$577
- RESOLUTE ONYX$249
- DRAGONFLY OPSTAR$241
- Pounce XL Thrombectomy$187
- Pounce LP Thrombectomy$187
- Pounce Thrombectomy$187
- AVVIGO Guidance System$172
- LIMFLOW SYSTEM$169
- ENSITE PRECISION$168
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$156
- JETI$145
- FLOWTRIEVER CATHETER, S$141
- CT THROMBECTOMY SYSTEM KIT$141
- JOT DX$139
- IN.PACT Admiral$138
- SUPERA$134
- Cardiva VASCADE MVP VVCS 6-12F$131
- ONYX FRONTIER$130
- OPTIS$117
How this compares
$82,596 in reported general payments places this provider in the 95th percentile of 827 cardiovascular disease providers in Ohio.
Other cardiovascular disease in Cambridge
- Guilherme AttizzaniCleveland$1.3M
- Gregory LamCircleville$428K
- Emil HayekHudson$379K
- Abraham LincoffCleveland$369K
- Oussama WazniCleveland$367K
- Ian NeelandCleveland$329K
- Kamal ShemisaCincinnati$314K
- Mehdi ShishehborElyria$237K
- Abdu HawwaGarfield Hts$234K
- Jayanta MukherjeeColumbus$227K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.